lactoferrin and Anemia--Aplastic

lactoferrin has been researched along with Anemia--Aplastic* in 6 studies

Other Studies

6 other study(ies) available for lactoferrin and Anemia--Aplastic

ArticleYear
Functional studies of maturing myeloid cells during ex vivo expansion for treatment of aplasia: feasibility of ex vivo expansion from cryopreserved bone marrow cell samples.
    Journal of hematotherapy, 1998, Volume: 7, Issue:1

    Ex vivo expanded CD34+ progenitor cells from fresh or cryopreserved primate bone marrow, induced to granulocytic differentiation with growth factors, were investigated to determine whether myeloid cells produced in liquid cultures have the normal biologic functions needed for the treatment of patients with neutropenia following high-dose chemotherapy or therapeutic or accidental radiation exposure. Human and simian (baboons or macaques) CD34+ cells were cultured with granulocyte-colony stimulating factor (G-CSF), stem cell factor (SCF), interleukin-1 (IL-1), IL-3, and IL-6, and assessed at 14 days of culture for their capacity to respond to different functional tests. Immunostaining revealed that human ex vivo expanded cells contained myeloperoxydase (MPO, 82% +/- 8%) and lactoferrin (LF, 30% +/- 6%) in their granules. Maturation of cultured cells was associated with stimulated chemotactic responsiveness and respiratory burst activity (superoxide anion and hydrogen peroxide production) in expansions from human, baboon, and macaque CD34+ progenitor cells. Mature cells obtained from ex vivo expansion of selected cryopreserved human bone marrow CD34+ cells presented reduced but significant functional activities (chemotactic responsiveness and hydrogen peroxide production) when compared with human peripheral blood neutrophils. The validation of nonhuman primate ex vivo expansion systems may permit their use as models of irradiation. The feasibility of ex vivo expansion from cryopreserved bone marrow cell samples may offer considerable opportunity for banking bone marrow for autologous transfusion.

    Topics: Anemia, Aplastic; Animals; Antigens, CD34; Cells, Cultured; Chemotaxis, Leukocyte; Cryopreservation; Feasibility Studies; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; Lactoferrin; Macaca fascicularis; Neutropenia; Papio; Peroxidase; Superoxides

1998
Plasma lactoferrin content in neutropenic patients: effects of treatment with recombinant granulocyte-macrophage colony-stimulating factor.
    Molecular biotherapy, 1992, Volume: 4, Issue:2

    Plasma lactoferrin content was measured before and after therapy with recombinant granulocyte-macrophage colony-stimulating factor in five patients with aplastic anaemia, six with myelodysplasia, and three with prolonged, severe, chemotherapy-induced neutropenia. Before therapy plasma lactoferrin content was uniformly low. However, patients with aplastic anemia and those with chemotherapy-induced neutropenia had a normal lactoferrin:neutrophil ratio. The low levels of plasma lactoferrin thus reflected the low granulocyte mass. On the other hand, patients with myelodysplasia also had reduced lactoferrin:neutrophil ratios, suggesting qualitative/quantitative abnormalities of neutrophil lactoferrin production. After treatment with granulocyte-macrophage colony-stimulating factor, plasma lactoferrin levels increased in patients with aplastic anemia and in those with chemotherapy-induced neutropenia who showed a neutrophil response to treatment. In these patients, the lactoferrin:neutrophil ratio became elevated, suggesting increased synthesis/release of lactoferrin from neutrophils. However, patients with myelodysplasia continued to show depressed lactoferrin:neutrophil ratios, even when there had been an increase in granulocyte count, suggesting persistent abnormalities of neutrophil lactoferrin production/release. The implications of these findings for treatment of neutropenic patients with granulocyte-macrophage colony-stimulating factors are discussed.

    Topics: Adult; Anemia, Aplastic; Antineoplastic Agents; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lactoferrin; Leukocyte Count; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Recombinant Proteins

1992
Relationship of plasma lactoferrin content to neutrophil regeneration and bone marrow infusion.
    Scandinavian journal of haematology, 1986, Volume: 36, Issue:1

    Plasma concentrations of lactoferrin were measured in immediately separated EDTA samples from 5 subjects who had received HLA identical bone marrow transplants for leukaemia or aplastic anaemia and from 7 subjects who were leukopenic as a consequence of chemotherapy for a variety of malignant conditions. Plasma lactoferrin concentrations were found to closely parallel the leucocyte count and were not found to either predict or to antedate leucocyte regeneration. Serial measurements of plasma lactoferrin in a subject with no circulating neutrophils who received a bone marrow graft revealed that the clearance of lactoferrin followed an exponential pattern and had an initial half time of 2.2 h.

    Topics: Agranulocytosis; Anemia, Aplastic; Bone Marrow Transplantation; Hematopoiesis; Humans; Kinetics; Lactoferrin; Lactoglobulins; Leukemia; Leukocyte Count; Neoplasms; Neutropenia; Neutrophils

1986
Plasma lactoferrin in patients with neutropenia.
    Blut, 1986, Volume: 52, Issue:5

    This study examines the role of plasma lactoferrin in the assessment of neutropenia. In particular, we have studied lactoferrin as an inhibitor of granulopoiesis and as an indicator of the size of the total blood granulocyte pool (TBGP). Plasma lactoferrin concentration was determined in a heterogeneous group of 30 patients with neutropenia. Serial plasma lactoferrin levels in a patient with cyclic neutropenia correlated with the cycles of the neutrophil count. Patients with splenomegaly had a grossly elevated lactoferrin:neutrophil ratio. Most chronic idiopathic neutropenia patients had no real clinical problems and a normal plasma lactoferrin level. The results provide further evidence to support the concept that plasma lactoferrin indicates the size of the TBGP and the lactoferrin: neutrophil ratio indicates the degree of granulocyte margination. There was no evidence to suggest that lactoferrin acting as a feedback inhibitor of granulopoiesis caused neutropenia in these patients.

    Topics: Agranulocytosis; Anemia, Aplastic; Bone Marrow Cells; Colony-Forming Units Assay; Felty Syndrome; Humans; Lactoferrin; Lactoglobulins; Methods; Neutropenia; Radioimmunoassay

1986
Quantitative cytochemistry of blood neutrophils in myelodysplastic syndromes and chronic granulocytic leukaemia.
    Cell biochemistry and function, 1983, Volume: 1, Issue:2

    Quantitative cytochemistry of components of blood neutrophil azurophilic granules (myeloperoxidase, chloroacetate esterase, beta-glucuronidase, and acid phosphatase) and specific granules (lactoferrin) has been performed by scanning and integrating microdensitometry in 13 patients with a myelodysplastic syndrome and 11 patients with chronic granulocytic leukaemia. Both patient groups showed a reduction of enzyme activity in azurophilic granules, and also of lactoferrin, consistent with abnormal development of neutrophil granules. These cytochemical changes in blood neutrophils are similar to those found in acute myeloid leukaemia, are consistent with a leukaemic maturation defect, and may be of diagnostic value.

    Topics: Acid Phosphatase; Adult; Anemia, Aplastic; Carboxylic Ester Hydrolases; Cytoplasmic Granules; Densitometry; Glucuronidase; Histocytochemistry; Humans; Hydrolases; Lactoferrin; Lactoglobulins; Leukemia, Myeloid; Leukocyte Count; Neutrophils; Peroxidase; Peroxidases

1983
[Immunocytochemical determination of lactoferrin from secondary granules of polynuclear neutrophils].
    Medicina clinica, 1983, Jul-16, Volume: 81, Issue:5

    Topics: Anemia, Aplastic; Cytoplasmic Granules; Humans; Lactoferrin; Lactoglobulins; Myeloproliferative Disorders; Neutrophils

1983